Pennsylvania Sues Character.AI Over Chatbots That Sounded Like Licensed Doctors
Pennsylvania's attorney general has filed suit against Character.AI, alleging that some of the company's chatbot personas presented themselves to users...
Month: August 2026
There Are Now Over 1,300 FDA-Cleared AI Medical Devices—Here’s Where They All Went
Sometime in January 2026, the FDA's running list of authorized artificial intelligence and machine learning-enabled medical devices quietly crossed the...
Swedish Physicists Built an AI That Watches Molecules Move—And It Could Slash Drug Testing Costs
A new AI model out of Sweden has become remarkably good at predicting how molecules evolve and interact over time,...
22 Hospitals in Two States Let AI Scan Every Chest X-Ray for Silent Killers
At Advocate Health facilities across Wisconsin and North Carolina, an AI imaging system now quietly reviews scans looking for the...
The FDA Just Cleared a Chatbot to Practice Medicine—With Guardrails
For the first time, the U.S. Food and Drug Administration has cleared a software-as-a-medical-device product built around a patient-facing large...
Apple Rebuilt Its Health App at WWDC 2026, Then Quietly Shelved the AI Coach Everyone Was Waiting For
Apple used its Worldwide Developers Conference, held June 8 to 13, 2026, to ship the most significant redesign of its...
Step on This $600 Scale and It Will Try to Catch Hypertension and Diabetes Before Your Doctor Does
Withings unveiled the Body Scan 2 at CES 2026 in January, a home health station that looks like a bathroom...
Recursion’s AI-Picked Cancer Drug Shrank Polyps in a Disease With No Approved Treatment
Recursion Pharmaceuticals published data on December 8, 2025 showing that REC-4881, a drug its AI platform selected through phenotypic screening...
This AI Patent Fixes a Problem Forensic Nurses Have Flagged for Years: Bruises Are Harder to See on Dark Skin
George Mason University's Injury Analytics Lab announced on August 12, 2026 that it has been awarded a patent for an...
An AI-Engineered Antibody for Severe Asthma Just Entered Two Global Phase III Trials
On December 1, 2025, Generate:Biomedicines announced it would launch two global Phase III trials, named SOLAIRIA-1 and SOLAIRIA-2, for GB-0895,...
